amgevita solution
amgen canada inc - adalimumab - solution - 50mg - adalimumab 50mg - disease-modifying antirheumatic agents
amgevita solution
amgen canada inc - adalimumab - solution - 50mg - adalimumab 50mg - disease-modifying antirheumatic agents
amgevita solution
amgen canada inc - adalimumab - solution - 50mg - adalimumab 50mg - disease-modifying antirheumatic agents
omvyence poudre pour solution
janssen inc - infliximab - poudre pour solution - 100mg - infliximab 100mg - disease-modifying antirheumatic agents
hadlima pushtouch solution
samsung bioepis co., ltd - adalimumab - solution - 40mg - adalimumab 40mg
hadlima solution
samsung bioepis co., ltd - adalimumab - solution - 40mg - adalimumab 40mg
ilaris solution
novartis pharmaceuticals canada inc - canakinumab - solution - 150mg - canakinumab 150mg - immunosuppressive agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 150mg - sarilumab 150mg - disease-modifying antirheumatic agents
kevzara solution
sanofi-aventis canada inc - sarilumab - solution - 200mg - sarilumab 200mg - disease-modifying antirheumatic agents
ilaris poudre pour solution
novartis pharmaceuticals canada inc - canakinumab - poudre pour solution - 150mg - canakinumab 150mg - immunosuppressive agents